Fred B. Craves, Director at PONIARD PHARMACEUTICALS, INC. (PARD), bought 12,600 shares at $3.95 ($50K) on 2008-01-11, disclosed to the SEC on 2008-01-14.
Open-market purchase of $50k PARD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.87 | 100 | $387 | 0.8% |
| 2 | $3.89 | 600 | $2K | 4.7% |
| 3 | $3.90 | 100 | $390 | 0.8% |
| 4 | $3.92 | 100 | $392 | 0.8% |
| 5 | $3.93 | 500 | $2K | 3.9% |
| 6 | $3.94 | 365 |
| $1K |
| 2.9% |
| 7 | $3.95 | 1,024 | $4K | 8.1% |
| 8 | $3.96 | 800 | $3K | 6.3% |
| 9 | $3.97 | 635 | $3K | 5.0% |
| 10 | $3.98 | 1,255 | $5K | 10.0% |
| 11 | $3.99 | 2,321 | $9K | 18.5% |
| 12 | $4.00 | 4,800 | $19K | 38.3% |
| Total | $3.98 avg | 12,600 | $50K | 100% |
| Filing → |
| MDGL | SELL | 2024-11-27 | $1.2M | — | Filing → |
| MDGL | SELL | 2024-05-16 | $9.3M | — | Filing → |
| MDGL | SELL | 2020-08-19 | $5.2M | — | Filing → |